Veterinary DNA Testing Market Size, Share and Growth Outlook 2026: By Animal Type (Dogs, Cats, Equine, Other Animals), By Test Type, By Sample Type, By End User, Companies to 2034.
The global Veterinary DNA Testing Market size is forecast to increase from $530.82 Million in 2026 to $1127.15 Million in 2034 at a CAGR of 9.87% between 2026 and 2034.
The Veterinary DNA Testing market report provides detailed analysis and outlook of Veterinary DNA Testing segments including By Animal Type (Dogs, Cats, Equine, Other Animals ), By Test Type (Breed Identification/Profile Tests, Genetic Disease Risk Tests, Health and Wellness Tests, Ancestry and Lineage Tests, Trait and Physical Characteristics Analysis), By Sample Type (Saliva/Buccal Swab, Blood, Semen, Fecal), By End User (Individual Pet Owners, Veterinarians and Researchers, Pet Breeders and Animal Shelters, Academic and Research Institutions) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Veterinary DNA Testing Industry Overview
Precision genomics is becoming a core component of modern veterinary diagnostics and animal health management.
The global veterinary DNA testing industry is expanding as genetic technologies become increasingly integrated into livestock production, companion animal healthcare, breeding programs, and disease prevention strategies. Veterinary organizations are utilizing molecular diagnostics, genomic sequencing, and predictive genetic analysis to identify inherited disorders, optimize breeding decisions, and support precision medicine approaches. Advances in bioinformatics, high-throughput testing, and biomarker discovery are enabling earlier disease detection and individualized treatment planning across animal populations. The market is also benefiting from greater collaboration between diagnostic companies and genomics specialists, allowing comprehensive genetic insights to be incorporated into routine veterinary practice while supporting long-term improvements in animal health, productivity, and welfare.
Strategic acquisitions and platform collaborations are expanding genomic capabilities across veterinary diagnostics.
Industry participants are strengthening competitive positions by combining genomic expertise with established diagnostic infrastructure. Zoetis entered into a definitive agreement to acquire Neogen Corporation's animal genomics business, integrating capabilities such as breed identification and genetic disease screening into its Precision Animal Health portfolio. The transaction enhances predictive genetic analysis for both livestock and companion animals while expanding individualized veterinary care. Meanwhile, VolitionRx announced a collaboration with Sysmex Corporation to optimize its proprietary Nu.Q® NETs assay on the Sysmex diagnostic platform. Although initially developed for human clinical applications, the underlying epigenetic research is also supporting development of blood-based diagnostic tests that improve disease detection and monitoring across veterinary medicine, demonstrating increasing technology convergence between human and animal healthcare.
Growing recognition of early genetic diagnosis is supporting broader adoption of molecular testing technologies.
The veterinary genetics landscape continues to benefit from scientific evidence highlighting the clinical value of early molecular diagnosis for rare inherited disorders. Following approval of the first treatment for Thymidine Kinase 2 Deficiency (TK2d), UCB published integrated safety and efficacy findings in Brain Communications demonstrating the importance of early genetic testing in identifying rare metabolic diseases and enabling timely targeted treatment. Although focused on human medicine, the findings reinforce broader industry recognition that molecular diagnostics are essential for precision therapeutic decision-making and improved patient outcomes. This trend is encouraging continued investment in advanced DNA testing technologies, biomarker discovery, and genomic screening platforms that can accelerate diagnosis, guide treatment selection, and expand precision healthcare applications across veterinary medicine.
Veterinary DNA Testing Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Veterinary DNA Testing market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Zoetis Inc., Neogen Corporation, IDEXX Laboratories, Inc., Embark Veterinary, Inc., Wisdom Panel (Kinship), Orivet Genetic Pet Care, Genetic Pet Care, DNA My Dog, GenSol Diagnostics, EasyDNA. The Veterinary DNA Testing market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Veterinary DNA Testing industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Veterinary DNA Testing industry include- Zoetis Inc., Neogen Corporation, IDEXX Laboratories, Inc., Embark Veterinary, Inc., Wisdom Panel (Kinship), Orivet Genetic Pet Care, Genetic Pet Care, DNA My Dog, GenSol Diagnostics, EasyDNA. The Veterinary DNA Testing market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Veterinary DNA Testing Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Veterinary DNA Testing market remains one of the strongest-performing segments in the country.
The US Veterinary DNA Testing Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Veterinary DNA Testing market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Veterinary DNA Testing industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Veterinary DNA Testing markets
Canada's strong Veterinary DNA Testing sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Veterinary DNA Testing market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Veterinary DNA Testing Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Veterinary DNA Testing market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Veterinary DNA Testing population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Veterinary DNA Testing industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Veterinary DNA Testing market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Veterinary DNA Testing sales through 2034
France Veterinary DNA Testing companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Veterinary DNA Testing Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Veterinary DNA Testing distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Veterinary DNA Testing Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Veterinary DNA Testing market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Veterinary DNA Testing industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Veterinary DNA Testing industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Veterinary DNA Testing Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Veterinary DNA Testing market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Veterinary DNA Testing market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Veterinary DNA Testing Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Veterinary DNA Testing Market Segmentation
By Animal Type
Dogs
Cats
Equine
Other Animals
By Test Type
Breed Identification/Profile Tests
Genetic Disease Risk Tests
Health and Wellness Tests
Ancestry and Lineage Tests
Trait and Physical Characteristics Analysis
By Sample Type
Saliva/Buccal Swab
Blood
Semen
Fecal
By End User
Individual Pet Owners
Veterinarians and Researchers
Pet Breeders and Animal Shelters
Academic and Research Institutions
Leading Companies in Veterinary DNA Testing Industry (2026)
Zoetis Inc.
Neogen Corporation
IDEXX Laboratories, Inc.
Embark Veterinary, Inc.
Wisdom Panel (Kinship)
Orivet Genetic Pet Care
Genetic Pet Care
DNA My Dog
GenSol Diagnostics
EasyDNA
Countries Included
The Veterinary DNA Testing market report provides detailed analysis and outlook of Veterinary DNA Testing segments including By Animal Type (Dogs, Cats, Equine, Other Animals ), By Test Type (Breed Identification/Profile Tests, Genetic Disease Risk Tests, Health and Wellness Tests, Ancestry and Lineage Tests, Trait and Physical Characteristics Analysis), By Sample Type (Saliva/Buccal Swab, Blood, Semen, Fecal), By End User (Individual Pet Owners, Veterinarians and Researchers, Pet Breeders and Animal Shelters, Academic and Research Institutions) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Veterinary DNA Testing Industry Overview
Precision genomics is becoming a core component of modern veterinary diagnostics and animal health management.
The global veterinary DNA testing industry is expanding as genetic technologies become increasingly integrated into livestock production, companion animal healthcare, breeding programs, and disease prevention strategies. Veterinary organizations are utilizing molecular diagnostics, genomic sequencing, and predictive genetic analysis to identify inherited disorders, optimize breeding decisions, and support precision medicine approaches. Advances in bioinformatics, high-throughput testing, and biomarker discovery are enabling earlier disease detection and individualized treatment planning across animal populations. The market is also benefiting from greater collaboration between diagnostic companies and genomics specialists, allowing comprehensive genetic insights to be incorporated into routine veterinary practice while supporting long-term improvements in animal health, productivity, and welfare.
Strategic acquisitions and platform collaborations are expanding genomic capabilities across veterinary diagnostics.
Industry participants are strengthening competitive positions by combining genomic expertise with established diagnostic infrastructure. Zoetis entered into a definitive agreement to acquire Neogen Corporation's animal genomics business, integrating capabilities such as breed identification and genetic disease screening into its Precision Animal Health portfolio. The transaction enhances predictive genetic analysis for both livestock and companion animals while expanding individualized veterinary care. Meanwhile, VolitionRx announced a collaboration with Sysmex Corporation to optimize its proprietary Nu.Q® NETs assay on the Sysmex diagnostic platform. Although initially developed for human clinical applications, the underlying epigenetic research is also supporting development of blood-based diagnostic tests that improve disease detection and monitoring across veterinary medicine, demonstrating increasing technology convergence between human and animal healthcare.
Growing recognition of early genetic diagnosis is supporting broader adoption of molecular testing technologies.
The veterinary genetics landscape continues to benefit from scientific evidence highlighting the clinical value of early molecular diagnosis for rare inherited disorders. Following approval of the first treatment for Thymidine Kinase 2 Deficiency (TK2d), UCB published integrated safety and efficacy findings in Brain Communications demonstrating the importance of early genetic testing in identifying rare metabolic diseases and enabling timely targeted treatment. Although focused on human medicine, the findings reinforce broader industry recognition that molecular diagnostics are essential for precision therapeutic decision-making and improved patient outcomes. This trend is encouraging continued investment in advanced DNA testing technologies, biomarker discovery, and genomic screening platforms that can accelerate diagnosis, guide treatment selection, and expand precision healthcare applications across veterinary medicine.
Veterinary DNA Testing Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Veterinary DNA Testing market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Zoetis Inc., Neogen Corporation, IDEXX Laboratories, Inc., Embark Veterinary, Inc., Wisdom Panel (Kinship), Orivet Genetic Pet Care, Genetic Pet Care, DNA My Dog, GenSol Diagnostics, EasyDNA. The Veterinary DNA Testing market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Veterinary DNA Testing industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Veterinary DNA Testing Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Veterinary DNA Testing companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Veterinary DNA Testing markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Veterinary DNA Testing industry include- Zoetis Inc., Neogen Corporation, IDEXX Laboratories, Inc., Embark Veterinary, Inc., Wisdom Panel (Kinship), Orivet Genetic Pet Care, Genetic Pet Care, DNA My Dog, GenSol Diagnostics, EasyDNA. The Veterinary DNA Testing market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Veterinary DNA Testing Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Veterinary DNA Testing market remains one of the strongest-performing segments in the country.
The US Veterinary DNA Testing Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Veterinary DNA Testing market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Veterinary DNA Testing industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Veterinary DNA Testing markets
Canada's strong Veterinary DNA Testing sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Veterinary DNA Testing market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Veterinary DNA Testing Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Veterinary DNA Testing market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Veterinary DNA Testing population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Veterinary DNA Testing industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Veterinary DNA Testing market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Veterinary DNA Testing sales through 2034
France Veterinary DNA Testing companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Veterinary DNA Testing Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Veterinary DNA Testing distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Veterinary DNA Testing Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Veterinary DNA Testing market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Veterinary DNA Testing industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Veterinary DNA Testing industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Veterinary DNA Testing Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Veterinary DNA Testing market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Veterinary DNA Testing market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Veterinary DNA Testing Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Veterinary DNA Testing Market Segmentation
By Animal Type
Dogs
Cats
Equine
Other Animals
By Test Type
Breed Identification/Profile Tests
Genetic Disease Risk Tests
Health and Wellness Tests
Ancestry and Lineage Tests
Trait and Physical Characteristics Analysis
By Sample Type
Saliva/Buccal Swab
Blood
Semen
Fecal
By End User
Individual Pet Owners
Veterinarians and Researchers
Pet Breeders and Animal Shelters
Academic and Research Institutions
Leading Companies in Veterinary DNA Testing Industry (2026)
Zoetis Inc.
Neogen Corporation
IDEXX Laboratories, Inc.
Embark Veterinary, Inc.
Wisdom Panel (Kinship)
Orivet Genetic Pet Care
Genetic Pet Care
DNA My Dog
GenSol Diagnostics
EasyDNA
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Veterinary DNA Testing Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Veterinary DNA Testing Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL VETERINARY DNA TESTING MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Veterinary DNA Testing Markets in 2026
3.2. Global Historic and Forecast Veterinary DNA Testing Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Veterinary DNA Testing Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Veterinary DNA Testing Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Veterinary DNA Testing Value Chain
CHAPTER 4- VETERINARY DNA TESTING MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Veterinary DNA Testing Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- VETERINARY DNA TESTING MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Animal Type
Dogs
Cats
Equine
Other Animals
By Test Type
Breed Identification/Profile Tests
Genetic Disease Risk Tests
Health and Wellness Tests
Ancestry and Lineage Tests
Trait and Physical Characteristics Analysis
By Sample Type
Saliva/Buccal Swab
Blood
Semen
Fecal
By End User
Individual Pet Owners
Veterinarians and Researchers
Pet Breeders and Animal Shelters
Academic and Research Institutions
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA VETERINARY DNA TESTING MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Veterinary DNA Testing Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Veterinary DNA Testing Market Trends and Growth Opportunities to 2034
7.5. North America Veterinary DNA Testing Market Size Outlook by Type
7.6. North America Veterinary DNA Testing Market Size Outlook by Application
7.7. North America Veterinary DNA Testing Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Veterinary DNA Testing Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Veterinary DNA Testing Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Veterinary DNA Testing Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Veterinary DNA Testing Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Veterinary DNA Testing Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Veterinary DNA Testing Companies
CHAPTER 8- EUROPE VETERINARY DNA TESTING MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Veterinary DNA Testing Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Veterinary DNA Testing Market Trends and Growth Opportunities to 2034
8.5. Europe Veterinary DNA Testing Market Size Outlook by Type
8.6. Europe Veterinary DNA Testing Market Size Outlook by Application
8.7. Europe Veterinary DNA Testing Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Veterinary DNA Testing Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Veterinary DNA Testing Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Veterinary DNA Testing Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Veterinary DNA Testing Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Veterinary DNA Testing Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Veterinary DNA Testing Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Veterinary DNA Testing Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Veterinary DNA Testing Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Veterinary DNA Testing Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Veterinary DNA Testing Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Veterinary DNA Testing Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Veterinary DNA Testing Companies
CHAPTER 9- ASIA PACIFIC VETERINARY DNA TESTING MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Veterinary DNA Testing Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Veterinary DNA Testing Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Veterinary DNA Testing Market Size Outlook by Type
9.6. Asia Pacific Veterinary DNA Testing Market Size Outlook by Application
9.7. Asia Pacific Veterinary DNA Testing Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Veterinary DNA Testing Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Veterinary DNA Testing Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Veterinary DNA Testing Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Veterinary DNA Testing Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Veterinary DNA Testing Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Veterinary DNA Testing Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Veterinary DNA Testing Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Veterinary DNA Testing Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Veterinary DNA Testing Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Veterinary DNA Testing Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Veterinary DNA Testing Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Veterinary DNA Testing Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA VETERINARY DNA TESTING MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Veterinary DNA Testing Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Veterinary DNA Testing Market Trends and Growth Opportunities to 2034
10.5. South and Central America Veterinary DNA Testing Market Size Outlook by Type
10.6. South and Central America Veterinary DNA Testing Market Size Outlook by Application
10.7. South and Central America Veterinary DNA Testing Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Veterinary DNA Testing Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Veterinary DNA Testing Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Veterinary DNA Testing Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Veterinary DNA Testing Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Veterinary DNA Testing Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Veterinary DNA Testing Companies
CHAPTER 11- MIDDLE EAST AND AFRICA VETERINARY DNA TESTING MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Veterinary DNA Testing Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Veterinary DNA Testing Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Veterinary DNA Testing Market Size Outlook by Type
11.6. Middle East and Africa Veterinary DNA Testing Market Size Outlook by Application
11.7. Middle East and Africa Veterinary DNA Testing Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Veterinary DNA Testing Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Veterinary DNA Testing Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Veterinary DNA Testing Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Veterinary DNA Testing Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Veterinary DNA Testing Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Veterinary DNA Testing Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Veterinary DNA Testing Industry
Zoetis Inc.
Neogen Corporation
IDEXX Laboratories, Inc.
Embark Veterinary, Inc.
Wisdom Panel (Kinship)
Orivet Genetic Pet Care
Genetic Pet Care
DNA My Dog
GenSol Diagnostics
EasyDNA
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Veterinary DNA Testing Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Veterinary DNA Testing Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL VETERINARY DNA TESTING MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Veterinary DNA Testing Markets in 2026
3.2. Global Historic and Forecast Veterinary DNA Testing Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Veterinary DNA Testing Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Veterinary DNA Testing Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Veterinary DNA Testing Value Chain
CHAPTER 4- VETERINARY DNA TESTING MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Veterinary DNA Testing Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- VETERINARY DNA TESTING MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Animal Type
Dogs
Cats
Equine
Other Animals
By Test Type
Breed Identification/Profile Tests
Genetic Disease Risk Tests
Health and Wellness Tests
Ancestry and Lineage Tests
Trait and Physical Characteristics Analysis
By Sample Type
Saliva/Buccal Swab
Blood
Semen
Fecal
By End User
Individual Pet Owners
Veterinarians and Researchers
Pet Breeders and Animal Shelters
Academic and Research Institutions
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA VETERINARY DNA TESTING MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Veterinary DNA Testing Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Veterinary DNA Testing Market Trends and Growth Opportunities to 2034
7.5. North America Veterinary DNA Testing Market Size Outlook by Type
7.6. North America Veterinary DNA Testing Market Size Outlook by Application
7.7. North America Veterinary DNA Testing Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Veterinary DNA Testing Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Veterinary DNA Testing Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Veterinary DNA Testing Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Veterinary DNA Testing Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Veterinary DNA Testing Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Veterinary DNA Testing Companies
CHAPTER 8- EUROPE VETERINARY DNA TESTING MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Veterinary DNA Testing Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Veterinary DNA Testing Market Trends and Growth Opportunities to 2034
8.5. Europe Veterinary DNA Testing Market Size Outlook by Type
8.6. Europe Veterinary DNA Testing Market Size Outlook by Application
8.7. Europe Veterinary DNA Testing Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Veterinary DNA Testing Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Veterinary DNA Testing Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Veterinary DNA Testing Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Veterinary DNA Testing Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Veterinary DNA Testing Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Veterinary DNA Testing Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Veterinary DNA Testing Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Veterinary DNA Testing Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Veterinary DNA Testing Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Veterinary DNA Testing Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Veterinary DNA Testing Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Veterinary DNA Testing Companies
CHAPTER 9- ASIA PACIFIC VETERINARY DNA TESTING MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Veterinary DNA Testing Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Veterinary DNA Testing Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Veterinary DNA Testing Market Size Outlook by Type
9.6. Asia Pacific Veterinary DNA Testing Market Size Outlook by Application
9.7. Asia Pacific Veterinary DNA Testing Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Veterinary DNA Testing Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Veterinary DNA Testing Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Veterinary DNA Testing Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Veterinary DNA Testing Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Veterinary DNA Testing Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Veterinary DNA Testing Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Veterinary DNA Testing Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Veterinary DNA Testing Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Veterinary DNA Testing Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Veterinary DNA Testing Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Veterinary DNA Testing Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Veterinary DNA Testing Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA VETERINARY DNA TESTING MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Veterinary DNA Testing Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Veterinary DNA Testing Market Trends and Growth Opportunities to 2034
10.5. South and Central America Veterinary DNA Testing Market Size Outlook by Type
10.6. South and Central America Veterinary DNA Testing Market Size Outlook by Application
10.7. South and Central America Veterinary DNA Testing Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Veterinary DNA Testing Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Veterinary DNA Testing Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Veterinary DNA Testing Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Veterinary DNA Testing Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Veterinary DNA Testing Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Veterinary DNA Testing Companies
CHAPTER 11- MIDDLE EAST AND AFRICA VETERINARY DNA TESTING MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Veterinary DNA Testing Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Veterinary DNA Testing Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Veterinary DNA Testing Market Size Outlook by Type
11.6. Middle East and Africa Veterinary DNA Testing Market Size Outlook by Application
11.7. Middle East and Africa Veterinary DNA Testing Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Veterinary DNA Testing Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Veterinary DNA Testing Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Veterinary DNA Testing Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Veterinary DNA Testing Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Veterinary DNA Testing Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Veterinary DNA Testing Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Veterinary DNA Testing Industry
Zoetis Inc.
Neogen Corporation
IDEXX Laboratories, Inc.
Embark Veterinary, Inc.
Wisdom Panel (Kinship)
Orivet Genetic Pet Care
Genetic Pet Care
DNA My Dog
GenSol Diagnostics
EasyDNA
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
